Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetic Neuropathies | 12 | 2022 | 40 | 2.050 |
Why?
|
Diabetes Mellitus, Experimental | 9 | 2022 | 190 | 1.530 |
Why?
|
Insulin-Secreting Cells | 8 | 2022 | 397 | 1.110 |
Why?
|
Hyperglycemia | 3 | 2015 | 176 | 0.810 |
Why?
|
Vital Statistics | 1 | 2018 | 3 | 0.690 |
Why?
|
Neural Conduction | 6 | 2020 | 69 | 0.680 |
Why?
|
Insulin | 10 | 2022 | 1160 | 0.630 |
Why?
|
Diabetes Mellitus | 4 | 2022 | 806 | 0.620 |
Why?
|
Gastric Inhibitory Polypeptide | 4 | 2018 | 9 | 0.540 |
Why?
|
Islets of Langerhans | 4 | 2022 | 544 | 0.520 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2011 | 55 | 0.510 |
Why?
|
Ganglia, Spinal | 5 | 2021 | 72 | 0.480 |
Why?
|
Glucagon | 3 | 2022 | 111 | 0.450 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2015 | 384 | 0.430 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 376 | 0.420 |
Why?
|
Feedback, Physiological | 1 | 2011 | 62 | 0.400 |
Why?
|
Mice, Inbred C57BL | 14 | 2020 | 3092 | 0.400 |
Why?
|
Liver Neoplasms | 4 | 2015 | 736 | 0.390 |
Why?
|
Mice | 27 | 2022 | 11352 | 0.390 |
Why?
|
Hepatocytes | 1 | 2011 | 127 | 0.380 |
Why?
|
Animals | 38 | 2022 | 26582 | 0.380 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 166 | 0.380 |
Why?
|
Antibodies, Antinuclear | 1 | 2010 | 83 | 0.360 |
Why?
|
Quality Control | 1 | 2010 | 117 | 0.360 |
Why?
|
Liver | 10 | 2017 | 1230 | 0.360 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 316 | 0.350 |
Why?
|
Weight Gain | 3 | 2018 | 123 | 0.340 |
Why?
|
Calmodulin | 2 | 2007 | 50 | 0.330 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2020 | 567 | 0.330 |
Why?
|
Rats | 13 | 2022 | 3990 | 0.310 |
Why?
|
Proglucagon | 3 | 2022 | 5 | 0.310 |
Why?
|
Stem Cells | 2 | 2020 | 351 | 0.310 |
Why?
|
Venoms | 1 | 2007 | 12 | 0.300 |
Why?
|
Fibroblast Growth Factors | 3 | 2017 | 80 | 0.300 |
Why?
|
Peptides | 3 | 2022 | 639 | 0.280 |
Why?
|
Gene Expression Regulation | 2 | 2011 | 1920 | 0.280 |
Why?
|
Hypoglycemic Agents | 2 | 2019 | 378 | 0.280 |
Why?
|
Diet, High-Fat | 2 | 2018 | 114 | 0.270 |
Why?
|
S100 Calcium Binding Protein beta Subunit | 2 | 2017 | 4 | 0.270 |
Why?
|
Peripheral Nerves | 2 | 2022 | 36 | 0.270 |
Why?
|
Endoplasmic Reticulum | 1 | 2007 | 250 | 0.270 |
Why?
|
Nerve Growth Factors | 1 | 2005 | 63 | 0.260 |
Why?
|
Neuropeptides | 1 | 2005 | 112 | 0.250 |
Why?
|
Neurotransmitter Agents | 1 | 2005 | 106 | 0.250 |
Why?
|
Neurons | 4 | 2021 | 1546 | 0.250 |
Why?
|
Electroretinography | 2 | 2020 | 76 | 0.240 |
Why?
|
Insulin Resistance | 5 | 2019 | 377 | 0.230 |
Why?
|
Diabetic Retinopathy | 2 | 2020 | 87 | 0.220 |
Why?
|
Histological Techniques | 1 | 2022 | 35 | 0.220 |
Why?
|
Culture Media, Conditioned | 2 | 2020 | 104 | 0.220 |
Why?
|
Diet, High-Protein | 1 | 2022 | 1 | 0.220 |
Why?
|
Apoptosis | 5 | 2021 | 1683 | 0.210 |
Why?
|
Cell Line | 7 | 2021 | 2468 | 0.210 |
Why?
|
Glucagon-Secreting Cells | 1 | 2022 | 25 | 0.210 |
Why?
|
Docosahexaenoic Acids | 1 | 2022 | 31 | 0.210 |
Why?
|
Dietary Carbohydrates | 2 | 2018 | 38 | 0.210 |
Why?
|
Nerve Fibers | 2 | 2019 | 46 | 0.200 |
Why?
|
Japan | 2 | 2019 | 307 | 0.200 |
Why?
|
Promoter Regions, Genetic | 3 | 2015 | 937 | 0.200 |
Why?
|
Peripheral Nervous System | 1 | 2021 | 21 | 0.200 |
Why?
|
Glucagon-Like Peptide-1 Receptor | 2 | 2019 | 35 | 0.200 |
Why?
|
Pyruvaldehyde | 1 | 2021 | 10 | 0.200 |
Why?
|
Tooth, Deciduous | 1 | 2020 | 3 | 0.200 |
Why?
|
Glucagon-Like Peptides | 1 | 2020 | 8 | 0.190 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2020 | 30 | 0.190 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2020 | 63 | 0.190 |
Why?
|
Point-of-Care Testing | 1 | 2020 | 24 | 0.190 |
Why?
|
Potassium Channels, Inwardly Rectifying | 2 | 2018 | 119 | 0.180 |
Why?
|
Thermosensing | 1 | 2019 | 3 | 0.180 |
Why?
|
Arginase | 4 | 2001 | 16 | 0.180 |
Why?
|
Tomography, Optical Coherence | 1 | 2020 | 130 | 0.180 |
Why?
|
Oxidative Stress | 2 | 2022 | 447 | 0.180 |
Why?
|
Spiro Compounds | 1 | 2019 | 25 | 0.180 |
Why?
|
Dental Pulp | 1 | 2019 | 4 | 0.180 |
Why?
|
Calcium Channels, L-Type | 1 | 2019 | 39 | 0.180 |
Why?
|
Rats, Wistar | 4 | 2019 | 297 | 0.180 |
Why?
|
Mice, Knockout | 6 | 2020 | 1924 | 0.170 |
Why?
|
Electrodiagnosis | 1 | 2019 | 7 | 0.170 |
Why?
|
Pyrazines | 1 | 2019 | 92 | 0.170 |
Why?
|
Exocytosis | 1 | 2019 | 108 | 0.170 |
Why?
|
Male | 22 | 2020 | 40958 | 0.170 |
Why?
|
Retina | 1 | 2020 | 213 | 0.170 |
Why?
|
Cyclin D2 | 1 | 2018 | 19 | 0.170 |
Why?
|
Bone Morphogenetic Protein 4 | 2 | 2015 | 15 | 0.160 |
Why?
|
Cell Nucleus | 3 | 2019 | 579 | 0.160 |
Why?
|
Glucose | 3 | 2018 | 638 | 0.160 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 183 | 0.160 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 141 | 0.160 |
Why?
|
Organ Specificity | 3 | 2017 | 258 | 0.160 |
Why?
|
Diet, Carbohydrate Loading | 1 | 2017 | 2 | 0.160 |
Why?
|
Dietary Sucrose | 1 | 2017 | 13 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 1373 | 0.150 |
Why?
|
Atherosclerosis | 1 | 2020 | 244 | 0.150 |
Why?
|
Cause of Death | 1 | 2018 | 277 | 0.150 |
Why?
|
Adenosine Triphosphate | 1 | 2018 | 314 | 0.150 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2017 | 27 | 0.150 |
Why?
|
Dietary Fats | 1 | 2018 | 135 | 0.150 |
Why?
|
Adipose Tissue, Brown | 1 | 2017 | 80 | 0.150 |
Why?
|
Mice, Transgenic | 7 | 2007 | 1540 | 0.150 |
Why?
|
Energy Metabolism | 3 | 2017 | 271 | 0.150 |
Why?
|
Myoblasts | 1 | 2017 | 31 | 0.150 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2017 | 45 | 0.150 |
Why?
|
Enzyme Inhibitors | 1 | 2019 | 639 | 0.140 |
Why?
|
Glycolysis | 1 | 2017 | 129 | 0.140 |
Why?
|
Autoantigens | 3 | 2002 | 127 | 0.140 |
Why?
|
Neuronal Outgrowth | 3 | 2020 | 5 | 0.140 |
Why?
|
Glucose Tolerance Test | 4 | 2019 | 228 | 0.140 |
Why?
|
Clostridium | 1 | 2015 | 21 | 0.130 |
Why?
|
Palmitic Acid | 1 | 2015 | 26 | 0.130 |
Why?
|
Sodium-Glucose Transporter 1 | 1 | 2014 | 4 | 0.130 |
Why?
|
Liver Diseases | 4 | 2001 | 238 | 0.130 |
Why?
|
Tissue Culture Techniques | 2 | 2011 | 79 | 0.120 |
Why?
|
Drug Hypersensitivity Syndrome | 1 | 2014 | 2 | 0.120 |
Why?
|
KATP Channels | 1 | 2014 | 19 | 0.120 |
Why?
|
Diabetic Foot | 1 | 2014 | 13 | 0.120 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 371 | 0.120 |
Why?
|
Roseolovirus Infections | 1 | 2014 | 7 | 0.120 |
Why?
|
Herpesvirus 6, Human | 1 | 2014 | 19 | 0.120 |
Why?
|
Fatty Liver | 1 | 2015 | 125 | 0.120 |
Why?
|
RNA, Messenger | 4 | 2020 | 1981 | 0.120 |
Why?
|
Humans | 25 | 2022 | 86617 | 0.120 |
Why?
|
Adipocytes, White | 1 | 2013 | 2 | 0.120 |
Why?
|
Red-Cell Aplasia, Pure | 1 | 2013 | 5 | 0.120 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2014 | 53 | 0.120 |
Why?
|
Cells, Cultured | 6 | 2020 | 2818 | 0.120 |
Why?
|
Keratinocytes | 1 | 2014 | 143 | 0.110 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 1208 | 0.110 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 191 | 0.110 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 623 | 0.110 |
Why?
|
Steroids | 1 | 2014 | 177 | 0.110 |
Why?
|
Blood Glucose | 3 | 2019 | 873 | 0.110 |
Why?
|
Receptors, Immunologic | 1 | 2013 | 135 | 0.110 |
Why?
|
Wound Healing | 2 | 2014 | 344 | 0.110 |
Why?
|
Neural Crest | 1 | 2012 | 25 | 0.110 |
Why?
|
Cell Communication | 1 | 2013 | 194 | 0.110 |
Why?
|
Peptide Fragments | 2 | 2012 | 460 | 0.110 |
Why?
|
Diet | 1 | 2015 | 443 | 0.100 |
Why?
|
Forkhead Box Protein O3 | 1 | 2011 | 20 | 0.100 |
Why?
|
Forkhead Box Protein O1 | 1 | 2011 | 23 | 0.100 |
Why?
|
Calcineurin | 1 | 2011 | 16 | 0.100 |
Why?
|
NFATC Transcription Factors | 1 | 2011 | 29 | 0.100 |
Why?
|
Cell Differentiation | 2 | 2015 | 1458 | 0.100 |
Why?
|
Response Elements | 1 | 2011 | 63 | 0.100 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2022 | 48 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2012 | 104 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2013 | 683 | 0.100 |
Why?
|
Carotid Intima-Media Thickness | 2 | 2020 | 38 | 0.100 |
Why?
|
Calcium Signaling | 1 | 2011 | 129 | 0.100 |
Why?
|
Surveys and Questionnaires | 1 | 2018 | 2501 | 0.100 |
Why?
|
DNA Methylation | 1 | 2015 | 628 | 0.090 |
Why?
|
Macrophages | 1 | 2013 | 554 | 0.090 |
Why?
|
Transcription, Genetic | 1 | 2015 | 1135 | 0.090 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2010 | 39 | 0.090 |
Why?
|
Protein Transport | 1 | 2011 | 411 | 0.090 |
Why?
|
Cytodiagnosis | 3 | 1985 | 42 | 0.090 |
Why?
|
Cell Survival | 3 | 2021 | 969 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2002 | 425 | 0.090 |
Why?
|
Autoantibodies | 2 | 2001 | 267 | 0.090 |
Why?
|
Biomarkers | 4 | 2013 | 1718 | 0.080 |
Why?
|
Signal Transduction | 2 | 2022 | 3241 | 0.080 |
Why?
|
Creatine Kinase | 2 | 1998 | 52 | 0.080 |
Why?
|
Middle Aged | 10 | 2020 | 25017 | 0.080 |
Why?
|
Neurites | 2 | 2021 | 35 | 0.080 |
Why?
|
Receptors, Glucagon | 2 | 2020 | 11 | 0.080 |
Why?
|
Transcription Factor CHOP | 1 | 2007 | 15 | 0.080 |
Why?
|
Molecular Chaperones | 1 | 2007 | 111 | 0.070 |
Why?
|
United States | 1 | 2018 | 6665 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 2007 | 179 | 0.070 |
Why?
|
Receptors, Gastrointestinal Hormone | 2 | 2018 | 5 | 0.070 |
Why?
|
Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2005 | 2 | 0.070 |
Why?
|
Streptozocin | 2 | 2016 | 54 | 0.070 |
Why?
|
Mice, Inbred ICR | 1 | 2005 | 70 | 0.070 |
Why?
|
Cyclic AMP | 2 | 2019 | 273 | 0.070 |
Why?
|
Adult | 5 | 2020 | 25640 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2007 | 227 | 0.070 |
Why?
|
Nuclear Proteins | 2 | 2017 | 696 | 0.070 |
Why?
|
Benzoates | 1 | 2005 | 44 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 879 | 0.060 |
Why?
|
Glucose Intolerance | 2 | 2018 | 96 | 0.060 |
Why?
|
Valine | 1 | 2005 | 69 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 1801 | 0.060 |
Why?
|
Tetrazoles | 1 | 2005 | 50 | 0.060 |
Why?
|
Diabetic Angiopathies | 1 | 2005 | 62 | 0.060 |
Why?
|
Female | 12 | 2020 | 44509 | 0.060 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2005 | 90 | 0.060 |
Why?
|
Benzimidazoles | 1 | 2005 | 140 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2019 | 2705 | 0.060 |
Why?
|
Recombinant Proteins | 2 | 2017 | 1014 | 0.060 |
Why?
|
tert-Butylhydroperoxide | 1 | 2022 | 2 | 0.050 |
Why?
|
NAD | 1 | 2022 | 65 | 0.050 |
Why?
|
Clonal Deletion | 1 | 2002 | 23 | 0.050 |
Why?
|
Receptors, Interleukin-2 | 1 | 2002 | 66 | 0.050 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2022 | 134 | 0.050 |
Why?
|
Pancreatic Hormones | 1 | 2022 | 15 | 0.050 |
Why?
|
Schwann Cells | 1 | 2022 | 34 | 0.050 |
Why?
|
Rats, Inbred F344 | 1 | 2022 | 156 | 0.050 |
Why?
|
Specimen Handling | 1 | 2022 | 98 | 0.050 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2022 | 64 | 0.050 |
Why?
|
Muscle, Skeletal | 2 | 2017 | 449 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2020 | 2232 | 0.050 |
Why?
|
Aged | 5 | 2020 | 18402 | 0.050 |
Why?
|
Retinal Photoreceptor Cell Outer Segment | 1 | 2020 | 3 | 0.050 |
Why?
|
Retinal Photoreceptor Cell Inner Segment | 1 | 2020 | 4 | 0.050 |
Why?
|
Thymus Gland | 1 | 2002 | 195 | 0.050 |
Why?
|
Pulse Wave Analysis | 1 | 2020 | 10 | 0.050 |
Why?
|
Retinal Pigment Epithelium | 1 | 2020 | 12 | 0.050 |
Why?
|
Cell Death | 1 | 2022 | 256 | 0.050 |
Why?
|
Tooth Exfoliation | 1 | 2020 | 2 | 0.050 |
Why?
|
Fovea Centralis | 1 | 2020 | 21 | 0.050 |
Why?
|
Ankle Brachial Index | 1 | 2020 | 27 | 0.050 |
Why?
|
Liver Transplantation | 2 | 2001 | 1268 | 0.050 |
Why?
|
Gene Expression | 1 | 2005 | 1284 | 0.050 |
Why?
|
Hyperalgesia | 1 | 2020 | 16 | 0.050 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2020 | 31 | 0.050 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2021 | 107 | 0.050 |
Why?
|
Retinal Ganglion Cells | 1 | 2020 | 66 | 0.050 |
Why?
|
Cell Separation | 1 | 2020 | 196 | 0.050 |
Why?
|
Autophagy | 1 | 2022 | 149 | 0.050 |
Why?
|
Electromyography | 1 | 2020 | 183 | 0.050 |
Why?
|
Aldehyde Reductase | 1 | 2019 | 9 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2020 | 6501 | 0.050 |
Why?
|
Carotid Arteries | 1 | 2020 | 127 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2002 | 372 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2001 | 268 | 0.040 |
Why?
|
Ribonucleoprotein, U1 Small Nuclear | 1 | 1999 | 2 | 0.040 |
Why?
|
Sensory Receptor Cells | 1 | 2019 | 35 | 0.040 |
Why?
|
Epidermis | 1 | 2019 | 100 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 1673 | 0.040 |
Why?
|
Immune Tolerance | 1 | 2002 | 337 | 0.040 |
Why?
|
Calcitonin | 1 | 2019 | 38 | 0.040 |
Why?
|
Phosphocreatine | 1 | 1998 | 14 | 0.040 |
Why?
|
Cell Movement | 2 | 2020 | 758 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 187 | 0.040 |
Why?
|
Motor Skills | 1 | 2019 | 71 | 0.040 |
Why?
|
Substance P | 1 | 2019 | 61 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2002 | 728 | 0.040 |
Why?
|
Transcription Factors | 2 | 2017 | 1565 | 0.040 |
Why?
|
Dendritic Cells | 1 | 2002 | 425 | 0.040 |
Why?
|
Neuroprotective Agents | 1 | 2019 | 94 | 0.040 |
Why?
|
ROC Curve | 1 | 2020 | 752 | 0.040 |
Why?
|
Patch-Clamp Techniques | 1 | 2019 | 396 | 0.040 |
Why?
|
Ultrasonography | 1 | 2020 | 695 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 480 | 0.040 |
Why?
|
In Vitro Techniques | 1 | 2019 | 989 | 0.040 |
Why?
|
Superoxide Dismutase | 1 | 2019 | 177 | 0.040 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 182 | 0.040 |
Why?
|
Starch | 1 | 2017 | 8 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 19 | 0.040 |
Why?
|
Uncoupling Protein 1 | 1 | 2017 | 35 | 0.040 |
Why?
|
Adipose Tissue, White | 1 | 2017 | 18 | 0.040 |
Why?
|
Antioxidants | 1 | 2019 | 223 | 0.040 |
Why?
|
Graft Survival | 1 | 2001 | 884 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 54 | 0.040 |
Why?
|
Mitochondria | 1 | 2021 | 535 | 0.040 |
Why?
|
Hexokinase | 1 | 2017 | 19 | 0.040 |
Why?
|
Oxyhemoglobins | 1 | 1996 | 31 | 0.040 |
Why?
|
Enzyme Induction | 1 | 2017 | 88 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 1999 | 246 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2017 | 46 | 0.040 |
Why?
|
Models, Statistical | 1 | 2020 | 574 | 0.040 |
Why?
|
Endotoxins | 1 | 1996 | 36 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2017 | 72 | 0.040 |
Why?
|
Hypertension | 1 | 2005 | 1141 | 0.030 |
Why?
|
Erythrocytes | 2 | 2001 | 255 | 0.030 |
Why?
|
Transcription Factor Pit-1 | 1 | 2015 | 6 | 0.030 |
Why?
|
LIM-Homeodomain Proteins | 1 | 2015 | 21 | 0.030 |
Why?
|
Ectoderm | 1 | 2015 | 29 | 0.030 |
Why?
|
Mouse Embryonic Stem Cells | 1 | 2015 | 11 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2019 | 3636 | 0.030 |
Why?
|
Paired Box Transcription Factors | 1 | 2015 | 50 | 0.030 |
Why?
|
Hepatectomy | 1 | 1996 | 166 | 0.030 |
Why?
|
Mice, Inbred BALB C | 3 | 2002 | 1047 | 0.030 |
Why?
|
Rats, Zucker | 1 | 2015 | 38 | 0.030 |
Why?
|
Graft Rejection | 1 | 2001 | 1065 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2019 | 1804 | 0.030 |
Why?
|
Phlorhizin | 1 | 2014 | 3 | 0.030 |
Why?
|
Diazoxide | 1 | 2014 | 19 | 0.030 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 1994 | 5 | 0.030 |
Why?
|
Lung Diseases | 1 | 1996 | 263 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1994 | 57 | 0.030 |
Why?
|
Growth Substances | 1 | 1994 | 80 | 0.030 |
Why?
|
Eye Proteins | 1 | 2015 | 128 | 0.030 |
Why?
|
Foot | 1 | 2014 | 50 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2015 | 118 | 0.030 |
Why?
|
Sulfonylurea Compounds | 1 | 2014 | 64 | 0.030 |
Why?
|
Receptor for Advanced Glycation End Products | 1 | 2013 | 17 | 0.030 |
Why?
|
Prognosis | 2 | 2019 | 3675 | 0.030 |
Why?
|
3T3-L1 Cells | 1 | 2013 | 32 | 0.030 |
Why?
|
Adipokines | 1 | 2013 | 19 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2013 | 46 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2013 | 31 | 0.030 |
Why?
|
Immunomodulation | 1 | 2013 | 55 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2013 | 154 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2013 | 164 | 0.030 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2012 | 6 | 0.030 |
Why?
|
Nerve Growth Factor | 1 | 2012 | 17 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2012 | 28 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2019 | 1578 | 0.030 |
Why?
|
Sciatic Nerve | 1 | 2012 | 33 | 0.030 |
Why?
|
Incretins | 1 | 2012 | 14 | 0.030 |
Why?
|
Gene Silencing | 1 | 2013 | 172 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2013 | 112 | 0.030 |
Why?
|
Mass Screening | 2 | 1989 | 617 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2013 | 160 | 0.030 |
Why?
|
Ovalbumin | 2 | 2002 | 109 | 0.030 |
Why?
|
Child | 2 | 2020 | 6926 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 536 | 0.030 |
Why?
|
Gene Deletion | 1 | 2012 | 329 | 0.030 |
Why?
|
Cell Lineage | 1 | 2012 | 273 | 0.020 |
Why?
|
Calcineurin Inhibitors | 1 | 2011 | 54 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 1219 | 0.020 |
Why?
|
Immunization, Secondary | 2 | 2002 | 30 | 0.020 |
Why?
|
Intestines | 1 | 1994 | 411 | 0.020 |
Why?
|
Skin | 1 | 2014 | 554 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2012 | 679 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2011 | 203 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2017 | 1196 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 407 | 0.020 |
Why?
|
Homeostasis | 1 | 2012 | 409 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 1991 | 115 | 0.020 |
Why?
|
Quality of Life | 1 | 1996 | 1583 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2012 | 1753 | 0.020 |
Why?
|
Cell Division | 2 | 2002 | 696 | 0.020 |
Why?
|
Obesity | 1 | 2013 | 963 | 0.020 |
Why?
|
Reference Values | 2 | 2001 | 674 | 0.020 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1989 | 275 | 0.020 |
Why?
|
Pattern Recognition, Automated | 2 | 1985 | 217 | 0.020 |
Why?
|
Oxygen Consumption | 2 | 1996 | 239 | 0.020 |
Why?
|
Valsartan | 1 | 2005 | 20 | 0.020 |
Why?
|
Biphenyl Compounds | 1 | 2005 | 68 | 0.020 |
Why?
|
Probability | 1 | 1985 | 355 | 0.010 |
Why?
|
Colonic Neoplasms | 2 | 2001 | 556 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 231 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1989 | 1204 | 0.010 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 2002 | 20 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1989 | 1075 | 0.010 |
Why?
|
Clonal Anergy | 1 | 2002 | 30 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2002 | 117 | 0.010 |
Why?
|
Convalescence | 1 | 2001 | 12 | 0.010 |
Why?
|
Hepatitis | 1 | 2001 | 35 | 0.010 |
Why?
|
Carbon Tetrachloride Poisoning | 1 | 2001 | 3 | 0.010 |
Why?
|
Calibration | 1 | 2001 | 99 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 7990 | 0.010 |
Why?
|
Cholangiocarcinoma | 1 | 2001 | 66 | 0.010 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 2001 | 69 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2002 | 209 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2002 | 272 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2001 | 131 | 0.010 |
Why?
|
Blotting, Western | 1 | 2001 | 782 | 0.010 |
Why?
|
Acute Disease | 1 | 2001 | 826 | 0.010 |
Why?
|
Blood Pressure | 1 | 2005 | 1143 | 0.010 |
Why?
|
Self Tolerance | 1 | 1999 | 24 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2001 | 456 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 1999 | 171 | 0.010 |
Why?
|
Galactosamine | 1 | 1998 | 8 | 0.010 |
Why?
|
Neoplasms | 3 | 1985 | 2898 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 1998 | 73 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 1998 | 73 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 1999 | 168 | 0.010 |
Why?
|
Transgenes | 1 | 1999 | 180 | 0.010 |
Why?
|
Lupus Nephritis | 1 | 1999 | 78 | 0.010 |
Why?
|
Necrosis | 1 | 1998 | 204 | 0.010 |
Why?
|
Rabbits | 1 | 1999 | 636 | 0.010 |
Why?
|
Isoenzymes | 1 | 1998 | 271 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 1998 | 286 | 0.010 |
Why?
|
Sulfur Dioxide | 1 | 1996 | 1 | 0.010 |
Why?
|
Mitochondria, Liver | 1 | 1996 | 27 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 1991 | 0.010 |
Why?
|
Hepatic Veins | 1 | 1996 | 27 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 1996 | 55 | 0.010 |
Why?
|
Oxidative Phosphorylation | 1 | 1996 | 49 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1996 | 63 | 0.010 |
Why?
|
Adenine Nucleotides | 1 | 1996 | 63 | 0.010 |
Why?
|
Neoplastic Cells, Circulating | 1 | 1996 | 70 | 0.010 |
Why?
|
Portal Vein | 1 | 1996 | 120 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 1996 | 109 | 0.010 |
Why?
|
Syndrome | 1 | 1996 | 446 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2001 | 1376 | 0.010 |
Why?
|
Sepsis | 1 | 1998 | 306 | 0.010 |
Why?
|
Fibroblast Growth Factor 10 | 1 | 1994 | 6 | 0.010 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 1994 | 10 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1994 | 256 | 0.010 |
Why?
|
Kinetics | 1 | 1996 | 1513 | 0.010 |
Why?
|
Gallbladder Neoplasms | 1 | 1993 | 22 | 0.010 |
Why?
|
Hemolysis | 1 | 1993 | 61 | 0.010 |
Why?
|
Epithelium | 1 | 1994 | 319 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1999 | 1195 | 0.010 |
Why?
|
Cytokines | 1 | 1996 | 776 | 0.010 |
Why?
|
Adolescent | 2 | 1996 | 8979 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1994 | 1041 | 0.010 |
Why?
|
Survival Rate | 1 | 1996 | 1860 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 1994 | 301 | 0.010 |
Why?
|
Computers | 2 | 1982 | 112 | 0.010 |
Why?
|
Molecular Weight | 1 | 1991 | 332 | 0.010 |
Why?
|
Chickens | 1 | 1991 | 212 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1991 | 290 | 0.010 |
Why?
|
Calpain | 1 | 1991 | 111 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1996 | 1313 | 0.010 |
Why?
|
Epithelial Cells | 1 | 1994 | 669 | 0.010 |
Why?
|
Brain | 1 | 1998 | 2216 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1996 | 2601 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1996 | 3357 | 0.000 |
Why?
|